insider24.ch
Company / strategic investorRegistered location :4005 Basel

Basilea Pharmaceutica AGDeclared Swiss shareholdings

Basilea Pharmaceutica AG: 1 Swiss companies with a declared holding, including Basilea Pharmaceutica AG, Allschwil. Latest filing: 04.05.2023.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
…
Swiss companies held
1
Largest position
25,14 %
Basilea Pharmaceutica AG, Allschwil
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
04.05.2023
Active since 2007

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held

Basilea Pharmaceutica AG, Allschwil

25,14 %04.05.2023
How to read these figures?

Rates come from the 16 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure1 controls

Controls

Group entities linked to this shareholder in joint disclosures.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 1

90 days · Downward crossings

0

visible history: 15

First disclosure: 28.12.2007Last disclosure: 04.05.2023

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings
6
Rights / derivatives
2
Sale positions
129

Latest shareholding disclosures

SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

25.14%Voting rights sold04.05.2023
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

24.35%Voting rights sold30.12.2022
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

32.92%Voting rights sold05.03.2021
Show 15 older disclosures
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

37.16%Voting rights sold25.07.2020
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

25.54%Voting rights sold29.04.2016
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

25.54%Voting rights sold29.04.2016
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

24.492%Voting rights sold23.01.2016
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

24.492%Voting rights sold23.01.2016
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

26.809%Voting rights sold17.12.2015
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

14.9%Voting rights sold16.01.2014
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

15.76%Voting rights sold07.12.2013
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

14.75%Voting rights sold05.11.2013
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

19.937%Voting rights sold25.06.2013
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

19.964%Voting rights sold25.05.2013
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

20.12%Voting rights sold08.12.2012
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

16.24%Voting rights sold18.12.2010
SaleShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Single shareholder

20.13%Voting rights sold30.07.2010
PurchaseShareholdings

Basilea Pharmaceutica AG, Allschwil

Basilea Pharmaceutica AG · Group of shareholders

15.75%Voting rights acquired28.12.2007

insider24.ch

Follow Basilea Pharmaceutica AG’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Management purchases in this portfolio

Loading activity…

    These figures aggregate public disclosures. They are not investment advice.

    Common questions

    Which Swiss companies are in Basilea Pharmaceutica AG’s disclosed portfolio?

    Basilea Pharmaceutica AG, Allschwil.

    What is Basilea Pharmaceutica AG’s latest disclosure?

    The latest available disclosure was published on 04.05.2023 and concerns Basilea Pharmaceutica AG, Allschwil. Threshold disclosures do not describe every purchase or sale.

    Explore further

    Recent insider purchases

    What are insiders doing at companies disclosed by this shareholder?

    All purchases this week

    Insider barometer

    Compare insider purchases and sales across the Swiss stock exchange over 30 days.

    View the Swiss barometer

    These signals are not investment advice.